Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry.

Pesarini G, Ferrero V, Tomai F, Paloscia L, De Cesare N, Tamburino C, Piscione F, Vassanelli F, Ribichini F; Dexamethasone-Eluting Stent Italian REgistry Investigators..

J Invasive Cardiol. 2009 Mar;21(3):86-91.

PMID:
19258636
2.

Steroid-eluting stents in patients with acute coronary syndrome: the dexamethasone eluting stent Italian registry.

Ribichini F, Tomai F, Paloscia L, Di Sciascio G, Carosio G, Romano M, Verna E, Galli M, Tamburino C, De Cesare N, Pirisi R, Piscione F, Lanteri G, Ferrero V, Vassanelli C; DESIRE investigators..

Heart. 2007 May;93(5):598-600. Epub 2006 Sep 27.

3.

Clinical and angiographic outcomes in elderly patients treated with endothelial progenitor cell capture coronary stents: results from a prospective single-center registry.

Azzarelli S, Galassi AR, Grosso G, Tomasello D, Campisano B, Giacoppo M, Argentino V, Amico F, Fiscella A.

J Invasive Cardiol. 2010 Dec;22(12):594-8.

4.
5.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.

6.

A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.

Xu B, Li JJ, Yang YJ, Ma WH, Chen JL, Qiao SB, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.

Chin Med J (Engl). 2006 Apr 5;119(7):533-8.

PMID:
16620692
7.

Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial).

Wojakowski W, Pyrlik A, Król M, Buszman P, Ochała A, Milewski K, Smolka G, Kawecki D, Rudnik A, Pawłowski T, Jadczyk T, Wyderka R, Cybulski W, Dworowy S, Tendera M.

Minerva Cardioangiol. 2013 Jun;61(3):301-11.

PMID:
23681133
8.

Long-term clinical and angiographic results of Sirolimus-Eluting Stent in Complex Coronary Chronic Total Occlusion Revascularization: the SECTOR registry.

Galassi AR, Tomasello SD, Costanzo L, Campisano MB, Barrano G, Tamburino C.

J Interv Cardiol. 2011 Oct;24(5):426-36. doi: 10.1111/j.1540-8183.2011.00648.x.

PMID:
22004600
9.

Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.

van der Hoeven BL, Pires NM, Warda HM, Putter H, Quax PH, Schalij MJ, Jukema JW.

Int J Cardiol. 2008 Feb 29;124(2):166-71. Epub 2007 Apr 3.

PMID:
17408773
10.

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.

Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ; SPIRIT III Investigators..

JAMA. 2008 Apr 23;299(16):1903-13. doi: 10.1001/jama.299.16.1903.

PMID:
18430909
11.

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP; REALITY Trial Investigators..

JAMA. 2006 Feb 22;295(8):895-904.

PMID:
16493102
12.

Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis.

König A, Leibig M, Rieber J, Schiele TM, Theisen K, Siebert U, Gothe RM, Klauss V.

Am Heart J. 2007 Jun;153(6):979.e1-8.

PMID:
17540198
13.

Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.

Kim WJ, Lee SW, Park SW, Kim YH, Yun SC, Lee JY, Park DW, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Lee BK, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Park WJ, Kim HS, Chae JK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Choi YJ, Cheong SS, Yang TH, Jang JS, Her SH, Park SJ; ESSENCE-DIABETES Study Investigators..

Circulation. 2011 Aug 23;124(8):886-92. doi: 10.1161/CIRCULATIONAHA.110.015453. Epub 2011 Aug 1.

14.

Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.

Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R; CREATE (Multi-Center Registry of Excel Biodegradable Polymer Drug-Eluting Stents) Investigators..

JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013.

15.
16.

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators..

JAMA. 2005 Sep 14;294(10):1215-23.

PMID:
16160130
17.

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, Angeloni G, Carosio G, Bonizzoni E, Colusso S, Repetto M, Merlini PA; SES-SMART Investigators..

JAMA. 2004 Dec 8;292(22):2727-34.

PMID:
15585732
18.

Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.

Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, Gai LY, Ge JB, Wang WM, Du ZM, Huo Y, Wang LF, Gao W, Chen JY, He B, Jia GL, Yang ZJ, Cao KJ, Li WM, Shen WF, Wan Z, Huang DJ, Zhu GY; CCSR Investigators..

Int J Cardiol. 2008 Apr 25;125(3):339-46. Epub 2007 Apr 16.

PMID:
17434617
19.

Elective stenting in small coronary arteries: results of the Italian prospective multicenter registry MICROSCOPE.

Airoldi F, Di Mario C, Presbitero P, Maiello L, Carcagnì A, Bortone A, Cremonesi A, Castriota F, Frasheri A, Rubino A, Pernice V, Rubartelli P, Reimers B, Colombo A.

Ital Heart J. 2002 Jul;3(7):406-11.

PMID:
12189969
20.

Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.

Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.

Minerva Cardioangiol. 2008 Feb;56(1):35-42.

PMID:
18432167

Supplemental Content

Support Center